We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$86.8M
Cap. Flow %
32.16%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

Rank Stock Value
1
O icon
Realty Income
O
+$931K
2
SKM icon
SK Telecom
SKM
+$871K
3
MRNA icon
Moderna
MRNA
+$825K
4
COP icon
ConocoPhillips
COP
+$786K
5
PXD
Pioneer Natural Resource Co.
PXD
+$785K

Top Sells

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$1.83M
2
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
+$1.76M
3
MOS icon
The Mosaic Company
MOS
+$928K
4
STR
Sitio Royalties
STR
+$559K
5
GFI icon
Gold Fields
GFI
+$512K

Sector Composition

Rank Sector Weight
1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLAD icon
251
Gladstone Capital
GLAD
$432M
$411K 0.15%
20,367
-3,687
-15% -$83.5K
OCSL icon
252
Oaktree Specialty Lending
OCSL
$1.04B
$409K 0.15%
20,813
+1,054
+5% +$22.2K
BRW
253
Saba Capital Income & Opportunities Fund
BRW
$335M
$404K 0.15%
50,372
-634
-1% -$5.31K
CCAP icon
254
Crescent Capital BDC
CCAP
$403M
$404K 0.15%
26,052
+221
+0.9% +$3.79K
AXSM icon
255
Axsome Therapeutics
AXSM
$12.3B
$393K 0.15%
10,259
+5,206
+103% +$165K
BBDC icon
256
Barings BDC
BBDC
$871M
$389K 0.14%
41,774
-4,520
-10% -$45.9K
PTCT icon
257
PTC Therapeutics
PTCT
$6.29B
$362K 0.13%
9,043
-991
-10% -$34.7K
GAIN icon
258
Gladstone Investment Corp
GAIN
$646M
$347K 0.13%
24,665
-2,280
-8% -$34.3K
ZLAB icon
259
Zai Lab
ZLAB
$2.11B
$335K 0.12%
9,669
+3,736
+63% +$132K
GBT
260
DELISTED
Global Blood Therapeutics, Inc.
GBT
$332K 0.12%
10,406
-4,532
-30% -$133K
BBIO icon
261
BridgeBio Pharma
BBIO
$16.5B
$324K 0.12%
35,646
+31,589
+779% +$264K
IMCR icon
262
Immunocore
IMCR
$1.76B
$318K 0.12%
8,513
+3,297
+63% +$107K
FOLD
263
DELISTED
Amicus Therapeutics
FOLD
$314K 0.12%
29,263
-6,537
-18% -$53.8K
BCIC
264
BCP Investment Corp
BCIC
$87.5M
$303K 0.11%
12,931
-54
-0.4% -$1.24K
AGIO icon
265
Agios Pharmaceuticals
AGIO
$2.25B
$302K 0.11%
13,602
+2,061
+18% +$46.6K
RARE icon
266
Ultragenyx Pharmaceutical
RARE
$2.68B
$292K 0.11%
4,895
+345
+8% +$21.2K
LEGN icon
267
Legend Biotech
LEGN
$3.7B
$290K 0.11%
5,274
+2,079
+65% +$87.8K
BTX
268
BlackRock Technology and Private Equity Term Trust
BTX
$933M
$289K 0.11%
36,387
+22,786
+168% +$205K
ONC
269
BeOne Medicines Ltd
ONC
$33.9B
$285K 0.11%
1,758
+422
+32% +$65.9K
SGEN
270
DELISTED
Seagen Inc. Common Stock
SGEN
$284K 0.11%
1,604
-971
-38% -$140K
DCPH
271
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$282K 0.1%
+21,427
New +$236K
MYOV
272
DELISTED
Myovant Sciences Ltd.
MYOV
$278K 0.1%
22,356
+11,701
+110% +$129K
LGND icon
273
Ligand Pharmaceuticals
LGND
$5.9B
$277K 0.1%
4,974
+809
+19% +$45.9K
FCRD
274
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$275K 0.1%
78,239
+5,870
+8% +$23K
ENTA icon
275
Enanta Pharmaceuticals
ENTA
$377M
$274K 0.1%
5,798
+445
+8% +$24.2K
9 10
11
12 13

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, Virtus ETF Advisers held 501 positions worth $270M, up 21% from $223M the previous quarter. Its ten largest holdings account for 7.5% of the portfolio.

Virtus ETF Advisers deployed $86.8M of net new capital in Q2 2022, opening 128 new positions and adding to 202 existing holdings. Its largest new stake was ConocoPhillips: 7,627 shares worth $685K.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Agnico Eagle Mines, an estimated $1.83M trimmed.

  • Virtus ETF Advisers's largest Q2 2022 buy was ConocoPhillips: 7,627 shares worth $685K.
  • Virtus ETF Advisers added most to Realty Income in Q2 2022, an estimated $931K increase.
  • Virtus ETF Advisers's biggest Q2 2022 reduction was Agnico Eagle Mines, cutting an estimated $1.83M.
  • Virtus ETF Advisers fully exited BP Midstream Partners LP Common Units representing Limited Partner Interests in Q2 2022, selling an estimated $1.76M.
  • Virtus ETF Advisers's ten largest holdings make up 7.5% of its $270M portfolio in Q2 2022.
  • Virtus ETF Advisers opened 128 new positions and closed 67 in Q2 2022.
  • Virtus ETF Advisers's portfolio value rose 21% quarter-over-quarter to $270M.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.